+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global End Stage Renal Disease Market by Treatment (Dialysis, Transplantation), Diagnosis (Blood Tests, Imaging Tests, Kidney Sample Removal For Testing), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337854
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The End Stage Renal Disease Market size was estimated at USD 46.29 billion in 2023, USD 53.09 billion in 2024, and is expected to grow at a CAGR of 14.80% to reach USD 121.65 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the End Stage Renal Disease Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the End Stage Renal Disease Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the End Stage Renal Disease Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Asahi Kasei Medical Co., Ltd., AstraZeneca, B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, Bristol-Myers Squibb Company, Davita Healthcare Partners Inc., Fresenius Medical Care AG & Co. KGaA, GlaxoSmithKline PLC, Kissei Pharmaceutical Co., Ltd, Medtronic PLC, Nikkiso Co., Ltd., Pfizer Inc., and Sanofi SA.

Market Segmentation & Coverage

This research report categorizes the End Stage Renal Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment
    • Dialysis
      • Hemodialysis
      • Peritoneal Dialysis
      • Wearable Artificial Kidney
    • Transplantation
  • Diagnosis
    • Blood Tests
    • Imaging Tests
    • Kidney Sample Removal For Testing
    • Urine Tests
  • End-User
    • Dialysis Centres
    • Hospital & Clinics
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the End Stage Renal Disease Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the End Stage Renal Disease Market?
  3. What are the technology trends and regulatory frameworks in the End Stage Renal Disease Market?
  4. What is the market share of the leading vendors in the End Stage Renal Disease Market?
  5. Which modes and strategic moves are suitable for entering the End Stage Renal Disease Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. End Stage Renal Disease Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Proliferation in number of people suffering from chronic kidney disease
5.1.1.2. Growing geriatric population with hypertension and diabetes
5.1.1.3. Increasing lifestyle changes and consumption of processed food
5.1.2. Restraints
5.1.2.1. Risk of complications
5.1.3. Opportunities
5.1.3.1. Introduction of new technologically enhanced products
5.1.3.2. Increasing investment in research and development activities coupled with collaborations among manufacturers
5.1.4. Challenges
5.1.4.1. Stringent regulatory protocols for the approval of new devices
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. End Stage Renal Disease Market, by Treatment
6.1. Introduction
6.2. Dialysis
6.3.1. Hemodialysis
6.3.2. Peritoneal Dialysis
6.3.3. Wearable Artificial Kidney
6.3. Transplantation
7. End Stage Renal Disease Market, by Diagnosis
7.1. Introduction
7.2. Blood Tests
7.3. Imaging Tests
7.4. Kidney Sample Removal For Testing
7.5. Urine Tests
8. End Stage Renal Disease Market, by End-User
8.1. Introduction
8.2. Dialysis Centres
8.3. Hospital & Clinics
8.4. Research & Academic Institutes
9. Americas End Stage Renal Disease Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific End Stage Renal Disease Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa End Stage Renal Disease Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Amgen Inc.
13.1.2. Asahi Kasei Medical Co., Ltd.
13.1.3. AstraZeneca
13.1.4. B. Braun SE
13.1.5. Baxter International, Inc.
13.1.6. Becton, Dickinson and Company
13.1.7. Bristol-Myers Squibb Company
13.1.8. Davita Healthcare Partners Inc.
13.1.9. Fresenius Medical Care AG & Co. KGaA
13.1.10. GlaxoSmithKline PLC
13.1.11. Kissei Pharmaceutical Co., Ltd
13.1.12. Medtronic PLC
13.1.13. Nikkiso Co., Ltd.
13.1.14. Pfizer Inc.
13.1.15. Sanofi SA
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. END STAGE RENAL DISEASE MARKET RESEARCH PROCESS
FIGURE 2. END STAGE RENAL DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. END STAGE RENAL DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. END STAGE RENAL DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. END STAGE RENAL DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. END STAGE RENAL DISEASE MARKET DYNAMICS
FIGURE 7. END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
FIGURE 10. END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. END STAGE RENAL DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. END STAGE RENAL DISEASE MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. END STAGE RENAL DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. END STAGE RENAL DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 6. END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 8. END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. END STAGE RENAL DISEASE MARKET SIZE, BY WEARABLE ARTIFICIAL KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 13. END STAGE RENAL DISEASE MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. END STAGE RENAL DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. END STAGE RENAL DISEASE MARKET SIZE, BY KIDNEY SAMPLE REMOVAL FOR TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. END STAGE RENAL DISEASE MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS CENTRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. END STAGE RENAL DISEASE MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. END STAGE RENAL DISEASE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 36. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 37. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 40. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 41. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. CHINA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. CHINA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 58. CHINA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 59. CHINA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. INDIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. INDIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 62. INDIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 63. INDIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. JAPAN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. JAPAN END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 70. JAPAN END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 71. JAPAN END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. THAILAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. THAILAND END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 94. THAILAND END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 95. THAILAND END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 107. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 108. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 111. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 112. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 115. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 116. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 120. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 124. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 131. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 132. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. NORWAY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. NORWAY END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 143. NORWAY END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 144. NORWAY END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. POLAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. POLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 147. POLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 148. POLAND END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 151. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 152. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 168. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. TURKEY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. TURKEY END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 179. TURKEY END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 180. TURKEY END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. END STAGE RENAL DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 190. END STAGE RENAL DISEASE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. END STAGE RENAL DISEASE MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amgen Inc.
  • Asahi Kasei Medical Co., Ltd.
  • AstraZeneca
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Bristol-Myers Squibb Company
  • Davita Healthcare Partners Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • GlaxoSmithKline PLC
  • Kissei Pharmaceutical Co., Ltd
  • Medtronic PLC
  • Nikkiso Co., Ltd.
  • Pfizer Inc.
  • Sanofi SA

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 53.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 121.65 Billion
Compound Annual Growth Rate14.8%
Regions CoveredGlobal

Related Topics

Related Reports

Global End Stage Renal Disease Market Analysis & Forecast to 2024-2034 - Product Image

Global End Stage Renal Disease Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
End-Stage Renal Disease - Global Strategic Business Report - Product Image

End-Stage Renal Disease - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
End-Stage Renal Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

End-Stage Renal Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 137 Pages
  • Global
From
End-Stage Renal Disease (ESRD) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

End-Stage Renal Disease (ESRD) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
End-Stage Renal Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

End-Stage Renal Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 78 Pages
  • Global
From

About the End Stage Renal Disease Drug Market

End Stage Renal Disease (ESRD) Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. ESRD drugs are used to treat patients with advanced kidney failure, who require dialysis or a kidney transplant. These drugs are used to reduce the symptoms of kidney failure, such as anemia, high blood pressure, and bone disease. They also help to reduce the risk of complications from dialysis and kidney transplantation. Common ESRD drugs include erythropoietin, calcitriol, and iron supplements. The ESRD Drug market is highly competitive, with many companies offering a variety of products. Major players in the market include Amgen, AstraZeneca, Baxter, Fresenius Medical Care, and Novartis. Other companies in the market include AbbVie, Allergan, Daiichi Sankyo, and Merck. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.